← Eichor
Study identifier: NCT06324396 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver Disease

Condition: Fontan Circulation  ·  Sponsor: Children's Mercy Hospital Kansas City

PhasePhase 1
Planned participants15
Who can joinAll sexes, 8 Years to no upper limit
Healthy volunteersNo

About this study

This is a single center, open-label, prospective, investigation to quantify the effects liver congestion and fibrosis has on hepatic drug metabolism and transport in children, adolescents, and young adults with Fontan circulation.

This description comes directly from the study's public registry record.

Talk to the study team

Jonthan Wagner, DO  ·  816-731-7240  ·  jbwagner@cmh.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Children's Mercy HospitalKansas City, Missouri, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06324396